Suministro de Dostarlimab (DOE), Niraparib(DOE) Y Mepolizumab(DOE)

Deadline:N/A

Contract award

Estimated value
€41,473,699.20
Duration
5 years
Bidders
Awarded bidders
Name
GLAXOSMITHKLINE, S.A.